Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - OTHER OPERATING ACTIVITIES
Other Operating Activities ESPR - Esperion Therapeutics, Inc.
48 M
LAST VALUE
16.19%
2 YEAR CAGR
194.90%
5 YEAR CAGR
48.23%
10 YEAR CAGR